2021-11-17

Pfizer and other three pharmaceutical companies were accused of selling vaccines to rich countries to earn $1000 per second!

By yqqlm yqqlm

Beijing, Nov. 17 (Xinhua) according to foreign media reports, a latest analysis shows that the total profits of Pfizer, biontech and Modena, the three pharmaceutical companies, reach an average of $65000 per minute; However, the majority of the population in the world’s poorest countries has still not been vaccinated

Pfizer and other three pharmaceutical companies were accused of selling vaccines to rich countries to earn $1000 per second!

on December 14, 2020 local time, nurses at Long Island Jewish Medical Center in New York showed the first batch of new crown vaccines in the United States. On the same day, Pfizer’s first batch of nearly 3 million doses of new crown vaccine successively arrived all over the United States. China News Agency reporter Liao panshe

the analysis and estimation of the non-profit organization “people’s vaccine alliance” according to the income reports of the three pharmaceutical manufacturers show that their pre tax profit this year can reach US $34 billion, equivalent to earning more than US $1000 per second, US $65000 per minute or US $93.5 million per day

“people’s vaccine alliance” also said that the three companies sold most vaccines to rich countries, but put low-income countries in trouble

the alliance called on pharmaceutical companies to join the agreement on trade related intellectual property rights proposed by the World Trade Organization and temporarily exempt the patent right of new crown vaccine, so as to increase vaccine production and help poor countries obtain vaccines faster

Seyoum, representative of the African branch of the people’s vaccine alliance, said: “Pfizer, biontech and Modena take advantage of their monopoly advantages to give priority to the most profitable contracts they have signed with the richest governments, but ignore the poor countries.”

the alliance pointed out that Pfizer biontech delivered less than 1% of its total vaccine supply to low-income countries, and Modena even less, only 0.2%. Currently, 98 per cent of people in low-income countries have not completed vaccination